What's driving the U.S. Clinical Nutrition Market Key Players are: Abbott Laboratories, B. Braun, Baxter, Danone, Fresenius Kabi, Hospira, Mead Johnson, Nestle and Perrigo

U.S. clinical nutrition market is expected to register substantial gains over the coming years. This can be primarily attributed to the booming elderly population in the country. With majority of the U.S. population following a sedentary lifestyle as well as unhealthy diet choices, the number of metabolic disorders such as diabetes and hypercholesterolemia is likely to rise, which will bolster the industry outlook.

On the basis of product, the market can be segmented into infant nutrition, parental nutrition, and enteral nutrition. Infant nutrition segment accounted for majority of the industry share and is estimated to record a healthy CAGR of more than 8% during the study timeframe. The growth can be credited to the awareness that adequate nutrition during infancy and early childhood is critical to ensure healthy growth and development of children to their full potential.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/4514

A substantial rise in the number of working mothers in the U.S. is anticipated to boost the market for infant nutrition supplements and products. Working mothers are increasingly being considered the backbone of the U.S. economy. With the increasing cost of living, working has become an economic necessity for many women in order to support their family. Today, over half of mothers with young children work, compared to just about one-third in the 1970s. Majority of women also return to work soon after giving birth due to the risk of losing future career opportunities.

This scenario will accelerate the consumption of different nutritional supplements for infants, including infant formulas. According to the U.S. Food and Drug Administration (FDA), a wide range of infant formulas is available on the market. FDA's nutrient specification for these formulas are set considering the nutritional needs of infants. The FDA also states that infants who are fed these formulas do not require additional nutrients, which will drive U.S. infant clinical nutrition market trends in the future.

Considering the device type, U.S. clinical nutrition market share can be classified into child and adult. Adult consumer segment was estimated to be worth more than US$4.8 billion in 2019 and is projected to hold a substantial revenue share over the next few years. This can be attributed to unhealthy lifestyle choices followed by majority of American adults and the consequent rise in the number of several chronic diseases.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/4514

Lack of proper physical activities is one of the major factors affecting majority of the adult population. It is estimated by the U.S. Department of Health & Human Services that less than 5% of American adults participate in at least 30 minutes of physical activity per day. In addition, the typical American diet exceeds the recommended levels of calories from solid and saturated fats, added sugars, sodium, and refined grains. Majority of Americans eat less than the recommended amounts of fruits, vegetables, dairy products and whole grains.

This has increased the rates of noncommunicable diseases, particularly chronic diet-related diseases. This includes various cardiovascular diseases, type-2 diabetes, high blood pressure, some cancers, and poor bone health. Poor eating and physical activity patterns among American adults have a cumulative effect and have resulted in numerous nutrition- and physical activity-related health challenges, which will propel the demand for adult clinical nutrition supplements and products.

Companies covered (9) in this report: Abbott Laboratories, B. Braun, Baxter, Danone, Fresenius Kabi, Hospira, Mead Johnson, Nestle and Perrigo

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.